PROGENICS PHARMACEUTICALS INC 4
4 · PROGENICS PHARMACEUTICALS INC · Filed Aug 8, 2013
Insider Transaction Report
Form 4
Youssoufian Hagop
Executive Vice President R&D
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2013-08-01$5.84/sh+150,000$876,000→ 150,000 totalExercise: $5.84Exp: 2023-08-01→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]The stock options become exercisable in four equal installments, commencing one year from the grant date.